Fluence Leads Global Research Initiative to Study Impact of Light Quality on Plant Development, Yield and Crop Quality – Financial Post

The ongoing multi-country and multi-crop initiative advances Fluences and the greater horticultural industrys understanding of the interaction between light and life

AUSTIN, Texas Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and agriculture production, has expanded its global photobiology research program, which encompasses studies on multiple vine crops, leafy greens and medical cannabis in the United States, Canada, Germany, Belgium and the Netherlands.

Tapping into a global network of trusted research institutions

Fluence leverages a network of leading research institutions and partners for its program, including Wageningen University & Research (WUR) for tomatoes; Proefstation voor de Groenteteelt (Proefstation) to study cucumbers; Harrow Research and Development Centre for peppers; The Technical University of Munichs Greenhouse Lab Centre for lettuce; Wageningen Plant Researchs Greenhouse Horticulture business unit and Compassionate Cultivation for medical cannabis.

The latest studies utilized Fluences VYPR Series top light and expanded PhysioSpec spectra offeringwhich features four spectra and market-leading efficacies up to 3.8 mol/Jin a randomized block design with triple replicates during a winter growing season. A leader in global horticultural research, WUR explored the impact of each spectrum on Merlice and Brioso tomato cultivars.

Traditionally, tomato plants are grown under high-pressure sodium lights, where only one spectrum is available to growers, said Ep Heuvelink, associate professor of horticulture and product physiology at WUR. Given the efficacy of Fluences LED solutions and the companys spectra options, its critical to understand how various tomato cultivars perform under LEDs and diversified spectra.

Featuring a 1.3-hectare greenhouse with 38 independent compartments, Proefstations facility brings more than 50 years of experience in research on the cultivation of greenhouse and field vegetables.

Light spectra have an important impact on plant and fruit quality, and weve found that LEDs provide a more optimal, precise spectrum than HPS, said Jonas De Win, lead cucumber researcher at Proefstation. This research is critical for our growers who frequently ask which spectra is best for their greenhouse and crop variety. Our goal is to act as the bridge between cucumber growers and the latest scientific research, enabling cultivators to enhance their environments and ultimately become more profitable.

Crop-based research results inform unique lighting strategies

LED lighting is a proven, viable option for global crop growers, said David Cohen, CEO of Fluence. Our exploration of the impact of light quality on plant development is driving a deeper conversation about efficacy, yield and quality between growers and their partners. Our commitment to leading cross-geography, multi-crop research will help guide growers in building a supplemental lighting strategy tailored to their unique business goals.

Fluence will distribute research results throughout the year, uncovering how the optimal lighting strategy varies by crop, species and environment. Results from Fluences cucumber trial with Proefstation will be previewed on July 15, 2020 on a webinar hosted by Leo Lansbergen, Fluences horticulture service specialist and expert in cucumber cultivation.

There is no one-size-fits-all approach to determining your lighting strategy, said David Hawley, Ph.D., Fluences senior scientist. Exploring how to manipulate LED technology presents a world of opportunity for us as scientists, but ultimately benefits growers looking to customize their cultivation environments. Insights derived from each study will help growers understand how various spectra impact harvests and plant quality, including factors ranging from nutrition and flavor to shelf life.

For more information about Fluence and its ongoing research initiatives, visit http://www.fluence.science.

About Fluence by OSRAM

Fluence Bioengineering, Inc., a wholly-owned subsidiary of OSRAM, creates powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier in the global cannabis market and is committed to enabling more efficient crop production with the worlds top vertical farms and greenhouse produce growers. Fluence global headquarters are based in Austin, Texas, with its EMEA headquarters in Rotterdam, Netherlands. For more information about Fluence, visit http://www.fluence.science.

Link to high resolution pictures: http://www.fluence.science/press-links

View source version on businesswire.com: https://www.businesswire.com/news/home/20200708005470/en/

Contacts

Media Contact: For North America, Emma Chase emma@redfancommunications.com Phone: 512-917-4319

For EMEA, Silvia Nagyova s.nagyova@osram.com Phone: +49 (89) 6213-3939

#distro

More:
Fluence Leads Global Research Initiative to Study Impact of Light Quality on Plant Development, Yield and Crop Quality - Financial Post

Transgene and Hypertrust Patient Data Care Announce Successful Go-Live of the World’s First Blockchain Solution for Clinical Trials of Personalized…

Regulatory News:

Transgene (Paris:TNG) and Hypertrust Patient Data Care today announced as a world premiere the first productive blockchain solution for clinical trials of personalized healthcare, leveraging the Hypertrust X-Chain for Clinical Trials product. The cloud-based solution monitors and orchestrates the supply chain processes of Transgene's AI-enhanced TG4050 individualized therapeutic vaccine based on the myvac technology, against ovarian, head and neck cancer providing an immutable audit trail throughout the treatment process.

The innovative collaboration between Transgene and Hypertrust marks a milestone in the ongoing fight against cancer. The blockchain-based Hypertrust X-Chain solution supports Transgene's personalized immunotherapies comprehensively, ensuring a trustworthy process in the background of the medical treatment. All emerging personalized treatments have a massive need for trustworthy and decentralized solutions, due to the strong cross-company collaborative nature of the production process.

Transgene's first individualized immunotherapy product candidate is based on the myvac technology. It is currently evaluated in two ongoing clinical trials, including patients in Europe and in the USA. This virus-based therapeutic vaccine encodes neoantigens (patient-specific mutations) that are identified and selected using state-of-the-art artificial intelligence capabilities. myvac-based products are designed to stimulate the patient's immune response, to recognize and destroy tumor cells based on their own mutations. This individualized immunotherapy is developed specifically for each patient.

"We have set up multiple collaborations around the world to allow each patient's anticancer therapy to be designed in a timely manner. Blockchain technologies are a perfect tool to ensure that the patient's genetic data are protected while ensuring that all the interventions of our partners are both smooth and tracked. We were very happy to collaborate with Hypertrust and together set up this novel process, demonstrating once again Transgene's ability to be at the forefront of innovation", commented Eric Qumneur, Pharm.D., Ph.D., Executive VP, Chief Scientific Officer of Transgene.

"We are very proud to present with our partner Transgene the world's first productive blockchain solution for clinical trials of personalized healthcare. The combination of Transgene's innovative and AI-enhanced TG4050 cancer vaccine, combined with the security and workflow orchestration features of our platform provides the optimum support for a highly personalized cancer treatment process", says Andreas Gbel, CEO of Hypertrust Patient Data Care.

Especially in clinical trials of personalized healthcare there is an essential need for an immutable audit trail, which is created by different parties throughout the supply and production process. Blockchain technologies bring a high level of trust, as it allows a total transparency on how the data were modified throughout the process and provide additional protection in an age of increasing cyberthreats.

Hypertrust X-Chain for Clinical Trials by Hypertrust Patient Data Care is a market-leading solution for the orchestration and documentation of clinical trials for personalized healthcare. It ensures the chain of identity and custody for personalized treatments in the context of clinical trials. The decentralized platform leverages blockchain technology, to provide closed-loop supply chain monitoring and orchestration, based on a workflow process definition. The solution provides an immutable and tamper-proof audit trail of all recorded data throughout the treatment. Also, it allows the migration towards the commercial scale solution "X-Chain for Commercialized Treatments".

About Transgene

Transgene (Euronext: TNG) is a publicly traded French biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. Transgene's programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells.

The Company's clinical-stage programs consist of two therapeutic vaccines (TG4001 for the treatment of HPV-positive cancers, and TG4050, the first individualized therapeutic vaccine based on the myvac platform) as well as two oncolytic viruses (TG6002 for the treatment of solid tumors, and BT-001, the first oncolytic virus based on the Invir.IO platform).

With Transgene's myvac platform, therapeutic vaccination enters the field of precision medicine with a novel immunotherapy that is fully tailored to each individual. The myvac approach allows the generation of a virus-based immunotherapy that encodes patient-specific mutations identified and selected by Artificial Intelligence capabilities provided by its partner NEC.

With its proprietary platform Invir.IO, Transgene is building on its viral vector engineering expertise to design a new generation of multifunctional oncolytic viruses. Transgene has an ongoing Invir.IO collaboration with AstraZeneca.

Additional information about Transgene is available at: http://www.transgene.fr or on Twitter: @TransgeneSA

About myvac

myvac is a viral vector (MVA) based, individualized immunotherapy platform that has been developed by Transgene to target solid tumors. myvac-derived products are designed to stimulate the patient's immune system, recognize and destroy tumors using the patient's own cancer specific genetic mutations. Transgene has set up an innovative network that combines bioengineering, digital transformation, established vectorization know-how and unique manufacturing capabilities. Transgene has been awarded an "Investment for the Future" funding from Bpifrance for the development of its platform myvac. TG4050 is the first myvac-derived product being evaluated in clinical trials.

About Hypertrust Patient Data Care

Hypertrust Patient Data Care provides next-generation digital health and supply chain solutions leveraging blockchain, AI and IoT. Hypertrust X-Chain delivers a blockchain-based solution securing a patient-centered closed-loop supply and distributed data chain for autologous cell therapies. Hypertrust X-Chain enables a safe, efficient and transparent workflow orchestration across the entire supply chain of autologous cell therapies with far-reaching benefits for pharma companies and all other stakeholders in the supply and data chain. Hypertrust Patient Data Care is a spin-off of CAMELOT Consulting Group.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200708005806/en/

Visit link:
Transgene and Hypertrust Patient Data Care Announce Successful Go-Live of the World's First Blockchain Solution for Clinical Trials of Personalized...

Impact of COVID-19 on Perfusion Bioreactor Market Overview with Detailed Analysis, Competitive Landscape & Forecast To 2026 – Owned

Innovative Report on Perfusion Bioreactor Market with Competitive Analysis, New Business Developments, and Top Companies

A perfect mix of quantitative & qualitative Perfusion Bioreactor Market Market information highlighting developments, industry challenges that competitors are facing along with gaps and opportunities available and would trend in Perfusion Bioreactor Market. The study bridges the historical data from 2014 to 2019 and estimated until 2026.

Prominent players profiled in the study: Sartorius AG, Infors HT, Pall, Thermo Fisher, 3D Biotek, GE Healthcare Life Sciences, Bioengineering AG, ZETA, Eppendorf AG, Applikon Biotechnology, PBS Biotech, Inc., Cell Culture Company, Zellwerk GmbH

Sample Report with Latest Industry Trends @https://www.acquiremarketresearch.com/sample-request/377887/

Covid-19 pandemic affects most industries in the globe. Here at acquire market research we offer you comprehensive data of related industry which will help and support your business in all possible ways.

This Report Provides an overview of the Perfusion Bioreactor market, containing global revenue, global production, sales, and CAGR. Also describe Perfusion Bioreactor product scope, market overview, market opportunities, market driving force, and market risks. The forecast and analysis of the Perfusion Bioreactor market by type, application, and region are also presented. The next part of the report provides a full-scale analysis of Perfusion Bioreactor competitive situation, sales, revenue and global market share of major players in the Perfusion Bioreactor industry. The basic information, as well as the profiles, applications, and specifications of products market performance along with Business Overview, are offered.

Small Scale (100 Liters), Mid-Scale (100 Liters to 1,000 Liters), Large Scale (>1,000 Liters): Small Scale (100 Liters), Mid-Scale (100 Liters to 1,000 Liters), Large Scale (>1,000 Liters)

Application: Biopharmaceutical, Biotechnology, Others

Geographical Regions: North America, Europe, Central & South America, Asia-Pacific, and the Middle East & Africa, etc.

Get Reasonable Discount on this Premium Report @https://www.acquiremarketresearch.com/discount-request/377887/

Scope of the Perfusion Bioreactor Report:

Worldwide Perfusion Bioreactor Market 2020, Market Size Value CAGR (XX %) and revenue (USD Million) for the historical years (2016 to 2019) and forecast years (2020 to 2026), with SWOT analysis, Industry Analysis, Demand, Sales, Market Drivers, Restraints, Opportunities and Forecast to 2026 cover in this research report.

As a part of our Corporate Social Responsibility, we would like to announce that we would be contributing 15 % of our profits to USA, UK, Italy, Spain and India relief fund.

This report covers the current scenario and growth prospects of the Perfusion Bioreactor Market for the period 2020-2026. The study is a professional and in-depth study with around tables and figures which provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the domain.

Finally, all aspects of the Global Perfusion Bioreactor Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and future prospects.

Browse Full [emailprotected] https://www.acquiremarketresearch.com/industry-reports/perfusion-bioreactor-market/377887/

About us:

Acquire Market Research is a market research-based company empowering companies with data-driven insights. We provide Market Research Reports with accurate and well-informed data, Real-Time with Real Application. A good research methodology proves to be powerful and simplified information that applied right from day-to-day lives to complex decisions helps us navigate through with vision, purpose and well-armed strategies. At Acquire Market Research, we constantly strive for innovation in the techniques and the quality of analysis that goes into our reports.

Contact Us:

Sally Mach555 Madison Avenue,5th Floor, Manhattan,New York, 10022 USAPhone No.: +1 (800) 663-5579Email ID: [emailprotected]

Read more here:
Impact of COVID-19 on Perfusion Bioreactor Market Overview with Detailed Analysis, Competitive Landscape & Forecast To 2026 - Owned

Wearable Physical Capacity Evaluation System Market 2020; Region Wise Analysis of Top Players in Market and its Types and Application – Express…

The research report on Wearable Physical Capacity Evaluation System market provides a detailed assessment of this business landscape. As per the report, the market is expected to generate substantial profit and showcase a notable growth rate of XX% during the analysis timeframe.

The report gives detailed insights regarding market segmentations, volume of sales, market competition trend, growth opportunities, predicted revenue generation, major manufacturers, and dealers. The report also emphasizes on the market risks and constraints. Additionally, the report includes various scenarios to assess the impact of COVID-19 on the growth of the Wearable Physical Capacity Evaluation System market.

Also, the research report underlines the key aspects of Wearable Physical Capacity Evaluation System market like the current revenue and production stats and estimates the upcoming prospects during the analysis period.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/140502

Detailing the regional analysis of the Wearable Physical Capacity Evaluation System market:

The report includes a thorough geographical analysis of this market bifurcating it into North America, Europe, Asia-Pacific, South America, Middle East & Africa, South East Asia.

Other takeaways of the Wearable Physical Capacity Evaluation System market report:

Market Status:The complete details on Wearable Physical Capacity Evaluation System Market situation, principal regions, distribution channels, pricing structures are blanketed.

Why Buy this Report?

Strategic Analysis Covered in TOC: - Key Topics Covered

Initially, the document offers an outline of the global market with a complete take a look at key drivers, constraints, challenges, traits and product types sold by using the employer. The file studies the Wearable Physical Capacity Evaluation System market capacity of key packages with the identity of forecast opportunities. The local evaluation with a focus on specific international locations and area of interest markets is presented. The pinnacle organization profiles with key-word market size and proportion estimation, revenue strategies, products, and other factors are studied.

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/140502

Go here to read the rest:
Wearable Physical Capacity Evaluation System Market 2020; Region Wise Analysis of Top Players in Market and its Types and Application - Express...

Single use Bioreactors Market Report 2020 by Global Key Players, Types, Applications, Countries, Market Size, Forecast to 2025 (Based on 2020 COVID-19…

The study on the Single Use Bioreactors Market by Adroit Market Research is a compilation of systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also offers a precise analysis of the key challenges and growth prospects awaiting key players of the Single Use Bioreactors Market, including a concise summary of their corporate strategies and competitive setting.

Download Premium Sample of the Report: https://www.adroitmarketresearch.com/contacts/request-sample/1467

The detailed market intelligence report on the Global Single Use Bioreactors Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Single Use Bioreactors Market place for the forecast 2019- 2025.

Global market report helps to identify opportunities in market place.

Global market report covers extensive analysis of emerging trends and competitive landscape.

Company Profiles include

Sartorius Stedim Biotech, Merck Millipore, GE Healthcare, Danaher, Thermo Fisher Scientific, Parker Hannifin, Applikon Biotechnology, Eppendorf, Cesco Bioengineering, Cellexus, Celltainer Biotech, PBS Biotech, Distek, Solida Biotech and Pierre Guerin

Read complete report with Toc at: https://www.adroitmarketresearch.com/industry-reports/single-use-bioreactors-market

Scope of the Report:

Report evaluates the growth rate and the Market value based on Market dynamics, growth inducing factors. The complete knowledge is based on latest industry news, opportunities and trends. The report contains a comprehensive Market analysis and vendor landscape in addition to a SWOT analysis of the key vendors.

Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Single Use Bioreactors Market.

Global market report covers in-depth historical and forecast analysis.

Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.

Single Use Bioreactors Market Segmentation:

Segmentation by Type:

by Type (Stirred-Tank Single use Bioreactor, Wave-Induced Single use Bioreactor, Bubble-Column Single use Bioreactor, Other Single use Bioreactor), Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, Other Cells) and Molecule (Monoclonal Antibodies, Vaccines, Stem Cells, Gene-Modified Cells, Other Molecules)

Segmentation by Application:

by Application (Research & Development, Process Development, Bioproduction)

This comprehensive report will provide:* Enhance your strategic decision making* Assist with your research, presentations and business plans* Show which emerging market opportunities to focus on* Increase your industry knowledge* Keep you up-to-date with crucial market developments* Allow you to develop informed growth strategies* Build your technical insight* Illustrate trends to exploit* Strengthen your analysis of competitors* Provide risk analysis, helping you avoid the pitfalls other companies could make* Ultimately, help you to maximize profitability for your company.

Our Market Research Solution Provides You Answer to Below Mentioned Question:1. Which are the driving factors responsible for the growth of market?2. Which are the roadblock factors of this market?3. What are the new opportunities, by which market will grow in coming years?4. What are the trends of this market?5. Which are main factors responsible for new product launch?6. How big is the global & regional market in terms of revenue, sales and production?7. How far will the market grow in forecast period in terms of revenue, sales and production?8. Which region is dominating the global market and what are the market shares of each region in the overall market in 2017?9. How will each segment grow over the forecast period and how much revenue will these segment account for in 2025?10. Which region has more opportunities?

To get this report at incredible Discounts, visit at: https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/1467

About Us :

Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us :

Ryan JohnsonAccount Manager Global3131 McKinney Ave Ste 600, Dallas,TX75204, U.S.A.Phone No.: USA: +1 972-362 -8199/ +91 9665341414

The rest is here:
Single use Bioreactors Market Report 2020 by Global Key Players, Types, Applications, Countries, Market Size, Forecast to 2025 (Based on 2020 COVID-19...

Industrial Bioprocessing Market Is expected to Witness Significant Growth between 2020 to 2025| Top Key Players- BD Biosciences, BioPharm…

Industrial Bioprocessing Market Overview 2020 2025

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The risingtechnology in Industrial Bioprocessing Marketis also depicted in thisresearchreport. Factors that are boosting the growth of the market, and giving a positive push to thrive in the global market is explained in detail.

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/20668

Key Competitors of the Global Industrial Bioprocessing Market are: , BD Biosciences, BioPharm International, GE Healthcare, Thermo Fisher Scientific, Danaher Corporation, Sartorius Stedim Biotech, Merck Millipore, 3M Company, Eppendorf AG, Finesse Solutions, Applikon Biotechnology B.V., Cesco Bioengineering,

Historical data available in the report elaborates on the development of the Industrial Bioprocessing on national, regional and international levels. Industrial Bioprocessing Market Research Report presents a detailed analysis based on the thorough research of the overall market, particularly on questions that border on the market size, growth scenario, potential opportunities, operation landscape, trend analysis, and competitive analysis.

Major Product Types covered are: , Upstream Bioprocessing, Downstream Bioprocessing,

Major Applications of Industrial Bioprocessing covered are: , Food, Medical, Pharmaceuticals and Nutraceuticals, Chemicals, Fuels, Others,

This study report on global Industrial Bioprocessing market throws light on the crucial trends and dynamics impacting the development of the market, including the restraints, drivers, and opportunities.

To get this report at a profitable rate.: https://reportsinsights.com/discount/20668

The fundamental purpose of Industrial Bioprocessing Market report is to provide a correct and strategic analysis of the Industrial Bioprocessing industry. The report scrutinizes each segment and sub-segments presents before you a 360-degree view of the said market.

Market Scenario:

The report further highlights the development trends in the global Industrial Bioprocessing market. Factors that are driving the market growth and fueling its segments are also analyzed in the report. The report also highlights on its applications, types, deployments, components, developments of this market.

Highlights following key factors:

:-Business descriptionA detailed description of the companys operations and business divisions.:-Corporate strategyAnalysts summarization of the companys business strategy.:-SWOT AnalysisA detailed analysis of the companys strengths, weakness, opportunities and threats.:-Company historyProgression of key events associated with the company.:-Major products and servicesA list of major products, services and brands of the company.:-Key competitorsA list of key competitors to the company.:-Important locations and subsidiariesA list and contact details of key locations and subsidiaries of the company.:-Detailed financial ratios for the past five yearsThe latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Our report offers:

Market share assessments for the regional and country level segments. Market share analysis of the top industry players. Strategic recommendations for the new entrants. Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets. Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations). Strategic recommendations in key business segments based on the market estimations. Competitive landscaping mapping the key common trends. Company profiling with detailed strategies, financials, and recent developments. Supply chain trends mapping the latest technological advancements.

Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://reportsinsights.com/industry-forecast/Industrial-Bioprocessing-Market-20668

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:[emailprotected]

Sales:[emailprotected]

Excerpt from:
Industrial Bioprocessing Market Is expected to Witness Significant Growth between 2020 to 2025| Top Key Players- BD Biosciences, BioPharm...

New records show 5,000+ contracts between big tech and the Pentagon – Business Insider – Business Insider

Ties between Silicon Valley and the Pentagon are deeper than previously known, according to thousands of previously unreported subcontracts published Wednesday.

The subcontracts were obtained through open records requests by accountability nonprofit Tech Inquiry. They show that tech giants including Google, Amazon, and Microsoft have secured more than 5,000 agreements with agencies including the Department of Defense, Immigrations and Customs Enforcement, the Drug Enforcement Agency, and the FBI.

Tech workers in recent years have pressured their employers to drop contracts with law enforcement and the military.

Google workers revolted in 2018 after Gizmodo revealed that Google was building artificial intelligence for drone targeting through a subcontract with the Pentagon after some employees quit in protest, Google agreed not to renew the contract. Employees at Amazon and Microsoft have petitioned both companies to drop their contracts with ICE and the military, but neither company has caved to the demands.

The newly-surfaced subcontracts published by Tech Inquiry show that the companies' connections to the Pentagon run deeper than many employees were previously aware. Tech Inquiry's research was led by Jack Poulson, a former Google researcher who left the company in 2018.

"Often the high-level contract description between tech companies and the military looks very vanilla and mundane," Poulson told NBC News. "But only when you look at the details of the contract, which you can only get through Freedom of Information [Act] requests, do you see the workings of how the customization from a tech company would actually be involved."

Subcontracts come about when one contractor can't carry out all the duties of their federal contract and hires a third party to fulfill certain aspects. In many cases, military and law enforcement contractors subcontracted with Google, Amazon, and Microsoft for services like cloud computing and data processing.

The research shows that Microsoft has over 5,000 subcontracts with law enforcement, while Amazon and Google each have several hundred subcontracts.

A Microsoft spokesperson declined to comment.

Representatives for Google and Amazon did not immediately respond to requests for comment.

Get the latest Google stock price here.

Read this article:

New records show 5,000+ contracts between big tech and the Pentagon - Business Insider - Business Insider

Here Come the 4 Horsemen of the Techopolypse – The New York Times

You can call it Techpalooza.

The chief executives of four of the most powerful tech companies in the world Apple, Facebook, Google and Amazon have agreed to appear in late July before a congressional committee as part of an investigation focused on antitrust.

Representative David Cicilline, a Democrat from Rhode Island who has become one of the biggest critics of Big Techs enormous power, told me on Wednesday that Jeff Bezos of Amazon, Mark Zuckerberg of Facebook, Sundar Pichai of Google and Tim Cook of Apple will testify in what could be an all-day event.

Mr. Cicilline said that the yearlong congressional investigation has included eight round-table discussions, 93 requests for information, 43 experts testifying and five hearings.

Its the first major look at antitrust in this industry in 50 years and a lot of people worldwide are watching how lawmakers deal with tech, he said. But throughout, we know it is impossible to properly conclude this without hearing from the decision makers themselves.

He said that all of the chief executives agreed to appear voluntarily and that logistics are still being worked out for what he hopes will be an in-person hearing in Washington. But safety concerns over the coronavirus may mean that the executives end up testifying remotely.

And while tech leaders have appeared before Congress in the past and there is often less illumination than noise at these kinds of hearings given the growing public alarm about the power of the tech giants, this gathering of the four horsemen of the Techopolypse could be an epic show. Winter may be coming for Silicon Valley.

Mr. Zuckerberg, Mr. Pichai and Mr. Bezos had indicated in letters previously that they were open to appearing at a hearing, after being invited by Mr. Cicillines antitrust subcommittee, while Apple had said that it was open to sending a top official.

Its clear that the chief executives wanted to appear together, not so much for support frenemies is about as close as I would describe them, and there is intense dislike between some of the companies but in the hopes that a group appearance will keep any one of them from being singled out for intense scrutiny. Some are suggesting that a multiday interrogation, with each chief executive facing a small number of experienced questioners, as well as real people they hurt, would be a better way to grill the tech moguls.

Still, if the lawmakers do their job in the planned format and ask pointed questions about the true impact of these companies power on competition, there could be some important moments.

This hearing will be part of a wider bipartisan inquiry into how the tech giants dominate the digital industry and hurt rivals and consumers.

Along with fines, politicians and regulators are contemplating new laws on privacy and competition, the repeal of a law that gives platforms broad immunity for content on their sites, and, perhaps most drastically, breaking them up.

And while each company has different problems such as a damaging role in the spread of disinformation and hate speech (Hello, Facebook!) the near monopolistic power of their services and what to do about it is the focus of the House investigation.

We have very serious concerns about the absence of competition, Mr. Cicilline said. So we are interested in a wide range of things like their acquisitions, bullying, market power, their favoring of their products and services.

While the House has been conducting its investigation, the Justice Department and the Federal Trade Commission have also been looking into competition in tech. So, too, have state attorneys general and also international regulators, most notably the European Commission under its antitrust head, Margrethe Vestager.

Too bad Ms. Vestager wont be asking these tech titans the questions she is the bane of the tech industrys existence, along with Senator Elizabeth Warren of Massachusetts. How the hearing will be conducted will be critical.

No surprise that I prefer public grillings with a side of shame, but more important will be how the companies portray themselves and how they differentiate themselves. While its convenient to apply the catchall term Big Tech to them, they are not a monolith and some in this group are further along in understanding that with great power comes great responsibility and, more important, accountability.

Hopefully, that is what we are going to finally see at the hearing. Mr. Cicilline said the House will issue a report of its findings later in the year, along with recommendations.

He also said that he had not been an expert in antitrust issues before he took over the helm of the antitrust subcommittee, but that the more I have studied and learned, the more terrifying the power of their large digital platforms is made clear, including the impact on innovation and start-ups.

At the heart of these inquiries, of course, is how can we continue to innovate as power has become more concentrated than ever. I have done innumerable interviews with start-ups and investors in which they talk about the chilling effect of big companies on their business.

Ask yourself, how easy it is to start an ad-based search engine, a social network, a major online retailer or an app platform when these companies completely cover the field with their money and power and might?

Answer: Its not easy, which is why I will try to grab a seat in the front row.

Continue reading here:

Here Come the 4 Horsemen of the Techopolypse - The New York Times

Dow gains more than 400 points after big tech rally, Amazon and Netflix hit records – CNBC

Stocks closed sharply higher on Monday, led by strong gains in the tech sector, as Wall Street built on the momentum from last week's solid performance and shook off a continued rise in coronavirus cases.

The Dow Jones Industrial Average rose 459.67 points, or 1.8%, to 26,287.03. The S&P 500 popped 1.6% to end the day at 3,179.72. The Nasdaq Compositehit an all-time high, surging 2.2% to 10,433.65.

There were a few reasons for the bullish lift to start the week:

"The economy is doing a lot better than most of the economists think," said Jeff Saut,chief investment strategist atCapital Wealth Planning, to CNBC's "Squawk Box" on Monday. "We may stall here for a while into the fall, into September, October, November, but I think you're going to get a rocket ship coming in the fall of this year...I think the S&P 500 is going to trade above 4,000."

Monday's gains came even asthe number of coronavirus cases kept surging globally, raising concerns about the world economy and its recovery from the pandemic.

The World Health Organization said Saturday that more than 200,000 coronavirus cases were confirmed over a 24-hour span, a record. At a regional level, the biggest spike was seen in the Americas, where nearly 130,000 new cases were confirmed.

In the U.S., coronavirus-related hospitalizations grew in more than 20 states, including, Florida, Texas, Arizona and Georgia.

"We are currently experiencing a spike in Covid-19 cases, particularly in the sunbelt states that were in the vanguard of loosening social distancing restrictions to facilitate the reopening of their economies," said Marc Chaikin, CEO of Chaikin Analytics, in a post.

"That reopening momentum has been halted by the spike in Covid-19 cases and the temptation to translate this into a bearish outlook for stocks is strong," he added. "Fatalities have not spiked, however, but are a lagging indicator. Thus the next two weeks are critical for a number of reasons."

Subscribe to CNBC PRO for exclusive insights and analysis, and live business day programming from around the world.

See the original post here:

Dow gains more than 400 points after big tech rally, Amazon and Netflix hit records - CNBC

Big Tech’s Washington hearing will be a spectacle for the ages – Financial Post

Strength in numbers or guilt by association?

When Jeff Bezos, Tim Cook, Sundar Pichai and Mark Zuckerberg appear together to answer questions from U.S. lawmakers in the coming weeks, it could be a watershed moment for Big Tech.

Their appearance before a House committee looking into whether Amazon.com Inc., Apple Inc., Alphabet Inc. and Facebook Inc. unfairly freeze out competition will mark the first time Congress has tried to hold Big Techs leaders jointly to account. The corporate power on display not to mention the combined wealth of a quarter of a trillion dollars will be unlike anything lawmakers have faced before.

The group hearing before the House judiciary committee, which the CEOs agreed to this week, means that they will escape the sort of grilling they could have expected had they appeared individually. There wont be time for lawmakers to drill too deeply into the complexities of the companies very different markets and business models.

But the spectacle of a joint hearing could more than make up for that by emphasizing their combined economic power. It also offers the chance to emphasize questionable business tactics they have in common such as the use of their dominant platforms to freeze out competitors and favour in-house services, whether by directing search queries (Google), promoting favoured products (Amazon) or integrating in-house services more closely with their hardware (Apple). If Big Techs critics were looking for the symbolic moment when the industry could be held to account, this could be it.

Inevitably, the hearing will be dismissed as political theatre though that will not lessen the anticipation. Theatrics count in the realm of antitrust, where investigations are often carried forward on the strength of political momentum and public opinion, even if any sanctions ultimately have to stand the test of court oversight. For politicians trying to drive home the need for action, there may be no better opportunity.

Congressional hearings that take the top leadership of entire industries to task have an honourable tradition. It is one that should make the tech bosses wary. Lining up a group of CEOs and getting them to raise their right hands in unison to be sworn in then sitting them shoulder to shoulder at a desk has obvious courtroom symbolism. It isnt just the imagery that matters: the process is also psychologically significant, throwing a group of wealthy corporate bosses, accustomed in the safety of their executive suites to feeling invulnerable, on to the defensive.

When the men in suits who controlled Big Tobacco were arrayed together on Capitol Hill in 1994, it became a turning point in forcing their industry to pay out billions of dollars in damages. Big Auto got a grilling in 2008, when the heads of the largest U.S. carmakers came cap in hand to Congress in the depths of the financial crisis to ask for a bailout (it didnt help that all three turned up in their corporate jets).

It will be harder for the lawmakers to land a similar blow on Big Tech. The pandemic is likely to rob the occasion of some of its dramatic potential. Rather than sitting alongside each other, facing a circle of inquisitors on an elevated platform, the four are more likely to be seen side by side in video windows on a Zoom screen. But, properly stage-managed, there should still be plenty of opportunity to make an impact.

By marshalling the meeting of the four CEOs, David Cicilline, the House judiciary committee chairman, has shown a keen awareness of the power of the moment. The canny Democratic congressman from Rhode Island has methodically worked through the detailed complaints of Big Techs critics, and called witnesses from the tech companies, in a series of hearings over the past year. He now has a chance to draw out the highlights, and to underline how much is at stake.

There are obvious pitfalls. One to avoid will be the spectacle presented by Zuckerbergs appearance before both branches of Congress after the Cambridge Analytica scandal came to light. The anger among politicians was palpable and the Facebook chief executive was widely criticized for being evasive. But he still managed to neutralize the political attacks, largely because of the uncoordinated and unfocused nature of the hearings.

Devising a format where the important issues can be aired at a high enough level, while at the same time leaving time to dig into the most egregious behaviour of the dominant tech companies, will be difficult. But if properly managed, it could prove an uncomfortable moment for leaders of some of the worlds most powerful companies.

2020 The Financial Times Ltd.

More here:

Big Tech's Washington hearing will be a spectacle for the ages - Financial Post

Samsung needs a splashy product for its splashy product launch – The Verge

The last big tech event I attended in person was Samsungs launch of the Galaxy S20 line of smartphones. Now Samsung will join everybody else in tech by trying to capture some semblance of that experience and hype in a purely online event with the upcoming Unpacked event scheduled for August 5th.

We are, of course, expecting to see the Galaxy Note 20 lineup announced that day. Though the rumors initially waffled a bit on what exactly that lineup would entail, more recent leaks point to a Note 20, a Note 20 Plus (which will be bigger), and a Note 20 Ultra (which will be... Ultra, whatever that means).

In addition to the Note 20 line, there are plenty of other Samsung devices that are due for an imminent release. Theres the 5G version of the Galaxy Z Flip folding phone, the Galaxy Z Fold 2 (rumors point to Z being Samsungs brand for screens that bend), the Galaxy Watch 3 smartwatch, and also new earbuds that are bean-shaped (yes really).

If all of these devices get announced, then it will be obvious that Samsung is hoping to make a splash with this event. Not to put too fine a point on it, but the company is broadcasting that intention quite clearly with a literal metallic paint splash on the invite.

As is Tradition, I will now proceed to overanalyze the image provided in a tech invitation. But while the normal rules require me to guess what products this image portends, instead I think it speaks to the psychology behind those products. Is it a halo? The drooping crown of a deposed king? Im just going to with saying it is what it looks like: a splash. Heres what it means: if the rumors hold true, this summers Unpacked event will see Samsung throw a bunch of ideas into the water to see what floats.

I get the feeling that Samsung is casting about for a halo device (something else that image could resemble, maybe). A halo device needs to impress everybody and draw people to the store, but not necessarily be the thing those people buy and walk out with. Will that be the Note 20, the Z Flip, or the Z Fold 2? I doubt Samsung itself knows the answer to that.

Me neither but my pessimistic take is Fold 2 or bust. Lets just review the contenders.

The Note 20 will surely be fine, but it will be laden with two problems. First, the spec-chasers will know that its just a Galaxy S20 with a stylus. Second, Samsungs big bet this year was on a new camera sensor that has been ...fine at best and problematic at worst.

Samsung was hoping for a generational leap, but instead tripped and has been trying to recover ever since. Reportedly, the Note 20 wont try to recreate the so-called 100X zoom but it will keep using that problematic 108-megapixel sensor. Even though Samsung has done much to improve it since the launch of the Galaxy S20 Ultra, its still worrisome.

The Galaxy Z Flip is genuinely better than any other clamshell folding phone (the main competitor being the new Razr), but the big issue I have with it is that it costs too much. I dont know whos clamoring for it to cost more. A 5G variant isnt the splash Samsung needs.

The Galaxy Watch? Itll be the best smartwatch for Android phones, which given the state of the competition means bupkis. As for the earbuds, all I want is for Samsung to have the self-confidence to actually call them beans. Tech is too self-serious these days. Give me Ear Beans.

But Ear Beans arent it either. Which leaves us with the Galaxy Z Fold 2 (or whatever it will be called. Im sure Samsung will throw a 5G in the name there in exchange for a carrier kickback).

I had a front-row seat to the disastrous Galaxy Fold launch in April of last year anytime your phone breaks spontaneously in the hands of several reviewers, thats bad. Samsung did eventually re-release the Fold (at its sky-high $1,980 price), but you wouldnt blame the company if it decided to just pull back on that whole folding tablet thing for a year or two.

Nope. If the rumors are true, the Fold 2 is coming. Now that is confidence. Rumors on what it will or wont be are a little more sparse than Id normally expect for a Samsung phone at this stage a larger outer screen, no stylus, and 5G. I also assume itll have that ultra-thin glass screen from the Z Flip. There will be more to the story, but that phone has a better shot at being a halo device than anything else.

Why does Samsung need a halo device? Because Chinese phone makers are nipping at its heels for marketshare (if not outright winning in lots of regions) and Samsung has staked its reputation on innovation. You can find a phone with 90 percent of what you get in a flagship Samsung phone while spending hundreds less so Samsung really needs to wow you with the other 10 percent.

The best wireless earbuds to buy right now. Im with Chris Welch on this one. After bouncing between five different BT headphones (AirPods Pro, Pixel Buds, Sony 1000XM3, OnePlus neckbuds, and the Galaxy Buds) for the past month, the Galaxy Buds are the ones I use the most now and notably, I use them with my Mac, iPhone, and Android phone. Would I like noise cancellation? Sure, but its not as much of a priority for me now that I dont commute by train. Id also like these headphones to switch between devices more seamlessly, but at least theyre better than Sony (nearly everybody is better than Sony in that regard).

Theres no one set of earbuds that is perfect at everything. For general everyday listening, the Samsung Galaxy Buds Plus are the best wireless earbuds. Got an iPhone? Nothing beats the AirPods Pro.

How I hosted my first charity stream, and how you can host one, too. Great walkthrough from Bijan Stephen:

If youre planning for your stream to be slightly more elaborate, I think the most important features to consider are length, guests, and a donation thermometer.

A portable display can make working from your dining room table easier. Dan Seifert:

Right now, the Ananta is available through a Kickstarter campaign, with deliveries promised for September of this year. As of this writing, the lowest price you can get the display for is $359, and it is expected to retail for a rather steep $599 when it hits general availability. If you go for the Kickstarter deal, the price is reasonable for how large, versatile, and well the Ananta works. But at full price, it may cost nearly as much as the laptop youre plugging it into, at which point you have to wonder if its worth it.

LG Gram 17 review: lighter than it looks. Monica Chin:

Its very unusual to see a 17-inch laptop under four pounds let alone under three. Couple that with a $1,499 starting price (our model currently goes for $1,699), and youre looking at a pretty niche target demographic. For that niche, though, this laptop tracks.

I built my own camera with a Raspberry Pi 4. This video from Becca Farsace is a treat. And it will encourage you to go try something weird and new during lockdown. Watch!

How to convert a PDF file for your Kindle.

This isnt a COVID-19 wave its a tsunami. Mary Beth Griggs has a much better metaphor for whats happening in the US right now.

Sports bubbles are good places to study COVID-19. Nicole Wetsman:

If the virus starts to spread within the isolation zones, though, it should be relatively easy to trace the path it traveled. In the outside world, its hard for people to remember where they go and who they interact with, says Angela Rasmussen, a research scientist at the Center for Infection and Immunity at the Columbia University Mailman School of Public Health. If youre on a tight schedule and living in a central location, like athletes in these environments are, that information is easy to access. You can work out, not only the number of contacts youve had, but the types of interactions you have with those people.

Tracing the link between your phone and the next pandemic. Justine Calma on how everything is connected. Mining for the minerals needed to make your phone puts people in situations that may cause spill over of viruses from animals to humans:

Ultimately, the way humans interact with animals and the environment can have grave consequences for our own well-being. Thats why scientists and public health experts have developed a strategy for addressing the ways in which the health of the environment and all of the people and wildlife living in it are connected. Its an approach called one health.

Microsoft announces new Windows 10 Start menu design and updated Alt-Tab. Tom Warren:

Essentially, the reduction in the color of the blocky tiled interface on the Start menu will simplify it slightly and make it easier to scan for the apps you use on a daily basis. Its a subtle change, but it certainly makes the Start menu look a little less chaotic and avoids many tiles sharing a similar blue color.

Microsoft announces Xbox Series X games event for July 23rd. How many times can you announce a new console?

Mmhmm turns your boring Zoom call into a Weekend Update-style TV show. If, like me, you briefly thought Oh I could probably pull all this off with OBS and a little work, youre missing the point. The whole key to this software is the ease of the UI, which could democratize different ways of presenting and having video conversations. I cant wait to try it out.

Google discontinues the Pixel 3A and 3A XL.

BMW is going all-in on in-car microtransactions. Well, I hate this! Sean OKane:

BMW now wants to take this to a far more specific level. The German automaker announced on Wednesday that all cars equipped with its newest Operating System 7 software will soon receive an update that makes it possible for the company to tinker with all sorts of functions in the car, like access to heated seats and driving assist features like automatic high beams or adaptive cruise control. And the company unsurprisingly plans to use this ability to make money.

Uber acquires meal delivery service Postmates for $2.65 billion.

Fading Light: the story of Magic Leaps lost mixed reality magnum opus. Adi Robertson:

Inside the company, though, a few dozen developers were building what they describe as one of Magic Leaps most exciting projects. Its called The Last Light: an interactive story about a young woman dealing with the death of her grandmother, designed to show the storytelling potential of mixed reality. And crucially, its creators say its finished but they arent sure if anyone will ever see it.

Theres no quick fix for climate change. Were so bad at understanding delayed results, as Justine Calma explains:

There is this fundamental misunderstanding of the climate system by non climate scientists trying to use trends on a 10 year time scale for climate change, when [with] climate change a 100 or 200-year timescale is relevant, explains Natalie Mahowald, a climate scientist at Cornell University who was not involved in the study. All our hard work today, we will not be able to see for 20 or 30 years this is the crux of the problem, Mahowald says. Humans have a really hard time doing something for future generations.

Quibi is flailing because no one at Quibi understands what Quibi is. Julia Alexander looks at the moves Quibi could make to survive as everybodys free trial runs out.

Visit link:

Samsung needs a splashy product for its splashy product launch - The Verge

Stocks Close Higher With Amazon and Netflix Making Big Gains – Barron’s

Text size

Wall Street returned from the long holiday weekend feeling bullish as U.S. stocks rallied on Monday and the Nasdaq Composite closed at a fresh high. Mondays advance was initially propelled by China, which saw the Shanghai Composite Index gaining 5.7%.

But as the day wore on, big tech drove the market even higher. The Dow Jones Industrial Average climbed 459.7 points, or 1.8%, to close at 26,287. The S&P 500 added 1.6%, while the Nasdaq Composite gained 2.2%.

Tech was largely behind Mondays rally with Amazon (ticker: AMZN) surging 5.8% to cross $3,000 apiece for the first time ever. Netflix (NFLX) shares climbed 3.6%, also notching an all-time high.

The Shanghai Composite surged to its highest level in over five years, and the Hang Seng rose nearly 4%, as a front-page editorial in Chinas state-run Securities Journal said a healthy bull market after the pandemic is now more important to the economy than ever.

That suggests the government is likely to do what it can to support the stock market, said Marshall Gittler, head of investment research at BDSwiss Group.

Markets across Asia and Europe rose. The Nikkei 225 rose 1.8% in Tokyo and the German DAX gained 1.6%.

Recent economic data has also helped fuel gains. Germany on Monday reported a 10.4% gain in new manufacturing orders for May, which nonetheless was 29.3% lower than a year ago.

The stock market gains come amid rising coronavirus case loads, particularly in southern parts of the U.S.

States containing over half the U.S. population now meet one or none of the Centers for Disease Control and Prevention-recommended gating criteria for reopening, point out analysts at Goldman Sachs, who separately downgraded their U.S. economic growth view for the year to a 4.6% contraction from a 4.2% downturn.

New York City entered the third phase of its reopening process on Monday, meaning that nail salons, tattoo parlors and other personal services are allowed to resume business. Indoor dining at restaurants is still on pause, however.

Oil wavered with the price of West Texas Intermediate crude falling 0.2% to $40.58 a barrel while the price of Brent crude popped 0.6% to $43.04 a barrel.

Goldman Sachs (GS) and Boeing (BA) led the Dow with shares climbing 5% and 3.9%, respectively. Walgreens Boots Alliance (WBA) was also a blue chip leader as shares rose 2.8%. Walgreens is set to report earnings on Thursday for its fiscal third quarter.

Uber Technologies (UBER) shares gained 6% after the company announced it would buy Postmates in a $2.65 billion stock deal. The move to buy the food-delivery service comes after attempts to acquire Grubhub (GRUB) fell through.

Dominion Energy (D) shares were down 11%. Dominion and Duke Energy (DUK) scrapped plans to build a natural gas pipeline under the Appalachian Trail due to legal uncertainty. Duke shares were off 2.5%.

Meanwhile, Warren Buffetts Berkshire Hathaway (BRK. B) announced Sunday it would buyDominions natural gas assets in a deal worth $10 billion, marking the Oracle of Omahas first major acquisition during the coronavirus pandemic. Berkshire stock was up 2.2% in Mondays trading.

Tesla (TSLA) shares jumped 13.5% following a bullish note from JMP Securities. Teslas shares have climbed roughly 40% over the last month. The electric car maker also appeared to mock short sellers over the holiday weekend by selling pairs of red shorts on its website.

Harley-Davidson (HOG) shares soared 7.4% after analysts at Citigroup initiated coverage on the motorcycle maker with a Buy rating and a $33 per share price target on hopes that Harley can stage a turnaround.

Write to Steve Goldstein at steven.goldstein@wsj.com and Carleton English at carleton.english@dowjones.com

Go here to read the rest:

Stocks Close Higher With Amazon and Netflix Making Big Gains - Barron's

COVID-19 Impact and Recovery Analysis | Artificial Intelligence (AI) Market In BFSI Sector 2019-2023 | Focus On Autonomous Banking to Boost Growth |…

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the artificial intelligence (AI) market in BFSI sector and it is poised to grow by USD 11.94 bn during 2019-2023, progressing at a CAGR of over 32% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download The Latest Free Sample Report of 2020-2024

The market is concentrated, and the degree of concentration will accelerate during the forecast period. Amazon Web Services Inc., Google LLC, IBM Corp., Microsoft Corp., and Oracle Corp. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Focus on autonomous banking has been instrumental in driving the growth of the market.

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations. https://www.technavio.com/report/report/global-artificial-intelligence-ai-market-in-BFSI-sector-industry-analysis

Artificial Intelligence (AI) Market in BFSI Sector 2019-2023: Segmentation

Artificial Intelligence (AI) Market in BFSI Sector is segmented as below:

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR31823

Artificial Intelligence (AI) Market in BFSI Sector 2019-2023: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The artificial intelligence (AI) market in BFSI sector report covers the following areas:

This study identifies the growing focus on personalized experience as one of the prime reasons driving the artificial intelligence (AI) market growth in BFSI sector during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports.Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Artificial Intelligence (AI) Market in BFSI Sector 2019-2023: Key Highlights

Table of Contents:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY END-USER

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

PART 13: VENDOR ANALYSIS

PART 14: APPENDIX

PART 15: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Continued here:

COVID-19 Impact and Recovery Analysis | Artificial Intelligence (AI) Market In BFSI Sector 2019-2023 | Focus On Autonomous Banking to Boost Growth |...

Artificial Intelligence Powered COVID-19 Diagnosis Tool to Seek Lung Scan Images from India – The Weather Channel

Representational image

Experts at University of British Columbia in Canada who are building an Artificial Intelligence-powered COVID-19 diagnosis tool with the help of resources from Amazon Web Services (AWS) are seeking lung scan images from India to refine their open source model, a researcher involved with the project said.

This tool is important because it becomes easier for doctors the world over to treat a patient if they know what disease they are suffering from and how badly that disease has infected that person.

The same goes with COVID-19 patients. Knowing that a person is COVID-19 positive can help, but this is not all that doctors want to know. They would do better if they knew how deep the infections were and how the patients were likely to respond to the treatments.

Now researchers know that lung images of COVID-19 patients can give them some clue to finding answers to these important questions.

That is the reason why a project was set up at the Cloud Innovation Centre (CIC) at the University of British Columbia (UBC) with the goal to develop and deploy an open source AI model capable of analysing CT scans of COVID-19 infected patients.

It aims to empower radiologists by providing metrics and statistical information about the infection that cannot normally be assessed by the human eye alone. The CIC at UBC is a public-private collaboration between UBC and AWS.

Recent literature suggests that the percentage of well-aerated-lung correlates to clinical outcomes, such as the need for ventilator support, ICU admission and death.

But the percentage of lung involvement, and inversely the percentage of well aerated lung, is difficult to accurately measure without advanced software tools, such as AI, said Savvas Nicolaou, Director of Emergency and Trauma Imaging at Vancouver General Hospital, as well as a Professor of Radiology at the University of British Columbia.

"We hope that utilising a machine to accurately calculate the lung involvement ratio and absolute volume will be a valuable metric for researchers to use to prognosticate patients with COVID-19 and other respiratory illnesses," Nicolaou told IANS in a video call.

The team leading the project worked with health centres around the world to assemble one of the largest international COVID-19 CT-scan datasets, but it could not immediately gather data from India at the start of the project due to the strict restrictions put in place in the country to fight the pandemic.

The dataset contains CT studies from countries such as Iran, Italy, Saudi Arabia, South Korea, and Canada to increase model generalisability, minimise bias, and establish an accurate model for any site.

The project dataset consists of COVID-19 positive scans as well as scans of patients with similar symptoms but are not COVID-19 positive.

By May this year, the "COVID-L3-Net" model was built on more than 1,100 CT scans. The team has collected another 3,100 scans from around the world that will be labeled to make the model even more accurate.

"The team welcomes scans from India. If radiologists or any medical professionals want to share their data sets and scans with the team, they need to reach out through the UBC Cloud Innovation Centre website," Nicolaou said.

"The team is also looking for researchers to test the model since it is in beta, and to receive feedback on the model," he said.

The data collaboration was possible due to an open-source tool called SapienSecure which was developed and released by a company named SapienML last year.

This open source app standardises the data de-identification of Personal Identifiable Information in medical imaging and helps to integrate directly into Amazon's storage service, Amazon S3, in the AWS Canada (Central) Region.

A team of more than 30 Vancouver General Hospital radiologists and UBC medical students coded the images, using software from MD.ai Inc.

Teams can remotely login, label and work on scans from home during this COVID-19 pandemic, all powered by Amazon compute instances.

"Right now, the team has released the model in pre-beta, and will be moving to beta soon. The goal is to have the model released in early September," Nicolaou said.

"The models keep getting better with more data, so we continue to collect more CT Scans from around the world," he added.

Continued here:

Artificial Intelligence Powered COVID-19 Diagnosis Tool to Seek Lung Scan Images from India - The Weather Channel

Artificial intelligence should be used to augment human creativity – not replace it – Bizcommunity.com

"It's easy for AI to come up with something novel just randomly. But it's very hard to come up with something that is novel and unexpected and useful." - John Smith, manager of Multimedia and Vision at IBM Research

Platforms such as Googles Smart Display and Dynamic Search and Facebooks Dynamic Creatives enable brands to automate the process of tailoring ads for different audiences and to do so at a highly granular level. In theory, this enables us to improve engagement and conversion by getting the right message to the right person at the right time.

But AI cannot be truly creative in the sense of using imagination to develop truly original ideas and make something. AI systems are limited by the original datasets humans give them to learn from. So, the question shouldnt be technology or creativity, but rather how AI can help creatives to meet their goals.

Getting it right isnt as simple as testing various combinations of assets to achieve the highest relevance for each person and to ensure the best results for the campaign goal. Its not just about putting together the right images and copy to address the needs of the user, but also about ensuring that the ad the person sees is interesting and emotionally engaging. Thats where human creativity comes in.

So where do brands, agencies and marketing teams go from here?

1. Start thinking about AI as an assistant for the creative team rather than a potential replacement for human insight and emotional intelligence. AI is invaluable and cost-effective for the rapid gathering of data and testing of different creative combinations, freeing up time for human creatives to dream up original thoughts and build emotionally engaging creative assets. Creatives and marketers will need to rapidly upskill to keep ahead of the tech advancements.

2. Marketers still need their creative agencies, perhaps more than ever. They should find ways to bridge the gaps between creative agencies and data & analytics teams and agencies. This will help them use data to drive better creative, while leveraging human strengths around cultural nuances, understanding human motivation, and original thinking.

3. Creative teams will need to move beyond the one killer concept or the one big idea towards developing multiple concepts that can be tested across various audience segments. The good news is that we can now try numerous ideas cheaply and rapidly without focus groups or surveys. This enables creatives to quickly create engaging assets and messages answering to different stages of the customer journey, and different consumer behaviours, demographics, interests and so forth.

4. Its time for media owners and digital media agencies to work more closely with creative agencies. A good media strategist will be able to offer a lot more value upfront when creatives are brainstorming rather than at the end. The role is no longer simply to select the best channels and propose the most suitable ad units, but also to help creatives to understand the potential of various channels and machine learning.

To close, here are some practical tips for AI-enabled creativity:

Excerpt from:

Artificial intelligence should be used to augment human creativity - not replace it - Bizcommunity.com

Forums held ahead of World Artificial Intelligence Conference – Chinadaily USA

A staff member demonstrates 5G-based remote control of a robot during the 2019 World Artificial Intelligence Conference (WAIC) in East China's Shanghai, on Aug 29, 2019. [Photo/Xinhua]

Three forums were held in Korea, Singapore and Germany prior to the official kickoff of the World Artificial Intelligence Conference 2020 on Thursday, with experts discussing topics from AI application scenarios to cross-border AI collaboration, according to a news release by the organizing committee released on Tuesday, also known as "WAIC2020 Global Day".

The release stated that representatives attending the forum in Singapore mapped out AI's widespread adoption throughout retail, medical care, education and financial services, and vowed to strengthen cooperation with China, and especially Shanghai, a city aiming to build itself into a global AI highland.

A total of five international exchange programs are scheduled to be held before and after the conference commences. These include an international summit on smart city, investment, AI innovation salon, international talent and a special roadshow for promising AI projects.

At least three cooperation deals are expected to be signed during the end of the conference, the committee said.

Read more from the original source:

Forums held ahead of World Artificial Intelligence Conference - Chinadaily USA

ContractPodAi and Bowmans Partner to Bring Artificial Intelligence-Powered Contract Management to the African Market – Business Wire

LONDON--(BUSINESS WIRE)--ContractPodAi, the award-winning provider of AI-powered contract lifecycle management solutions, today announced that it is partnering with Bowmans, one of Africas leading corporate law firms, to introduce Bowmans clients to its advanced technology solution. All this allows corporate legal teams to work smarter, faster and with far greater impact during the contracting process.

ContractPodAi is one of the worlds most robust contract lifecycle management (CLM) technologies, providing corporate legal counsels with a platform that provides end-to-end contract management capabilities like a smart contract repository, contract automation, document e-signatures, seamless workflows, third party contract review, negotiating and collaboration tools, and AI-based analytics.

As part of its digitisation strategy, Bowmans is strengthening its technology solutions toolkit. The firm is partnering with ContractPodAi because it offers a robust and graphically intuitive contract management system that streamlines document automation processes.

Craig Kennedy, Head of Technology, Media and Telecommunications at Bowmans, said: Part of the value we add to our clients businesses is the ability to support them in exploring and identifying suitable digital solutions to streamline their legal services.

With ContractPodAi, we saw an opportunity to help them to focus on strategic initiatives by implementing a technology solution that replaces time-consuming manual efforts.

ContractPodAi offers customers intelligent AI functionality, built on the trusted IBM Watson, and Microsoft Azure AI platforms, right out-of-the box. Its like getting the safety of IBM and Microsoft with the speed of a startup. A big part of whether CLM technology is successful within a company is its adoption with the business users, and legal team. Beyond the intuitive graphical user interface, a client success manager (CSM) supports every customer. Digital transformation is a challenge for any industry, and legal is no exception. As such the CSM facilitates adoption and encourages internal advocacy and education of every rollout.

We are thrilled to partner with an innovative African law firm like Bowmans to introduce our contract management solution to the African market, said Sarvarth Misra, co-founder and CEO, ContractPodAi. It is exciting to work with a firm that embraces the use of technology and is dedicated to making their clients successes a priority.

Learn how ContractPodAi is empowering legal teams across the world at ContractPodAi.com.

About ContractPod Technologies (ContractPodAi)

A pioneer in the legal transformation space, ContractPodAi is now one of the worlds fastest growing legal tech companies. Customers include some of the worlds largest and highly regarded corporations. ContractPodAi is an award-winning easy to use, intuitive and affordable end-to-end contract lifecycle management solution aimed at corporate legal departments. It enables users to assemble, automate, approve, digitally sign and manage all their contracts and documents from one place.

Our platform is built in partnership with some of the most trusted technologies in the industry including IBM Watson AI, Microsoft Azure, DocuSign and Salesforce. ContractPodAi is headquartered in London and has global offices in San Francisco, New York, Glasgow, Mumbai and Toronto. More information is available at ContractPodAi.com.

About Bowmans

With over 400 specialist lawyers, Bowmans draws on its unique knowledge of the business and socio-political environment in Africa to advise on a wide range of legal issues.

Everywhere it operates, Bowmans offers its clients a service that uniquely blends expertise in the law, knowledge of the local market and an understanding of their businesses. The firms aim is to assist its clients to achieve their objectives as smoothly and efficiently as possible while minimising the legal and regulatory risks.

Clients include corporates, multinationals and state-owned enterprises across a range of industry sectors as well as financial institutions and governments.

See more here:

ContractPodAi and Bowmans Partner to Bring Artificial Intelligence-Powered Contract Management to the African Market - Business Wire

VeChain Is Attending the World Artificial Intelligence Conference 2020 Hosted – AiThority

VeChain will be opening the first blockchain technology session in this conference, with our session titledblockchainize the future, power the economy.

The blockchain forum will be co-hosted by theShanghai Municipal Commission Of Economy And Informatization,Shanghai Finance Information Associationand several other large enterprises and organizations. VeChain will be sharing our experience in the blockchain deployment, integration and usage for various business scenarios and current successful users.

Recommended AI News:Azure DevSecOps Jumpstart Now Available In The Microsoft Azure Marketplace

Since the first WAIC in 2018, the event has become a grand meeting and festival, accumulating international influences across various industries. In line with the growing trend of the online new economy and digital transformation, this years conference will be inviting top-of-line tech enterprises, including Microsoft, Amazon, Alibaba,Tencent, Huawei and more.

This event will be the perfect avenue for VeChain to showcase our industry-leading blockchain infrastructure and technology. As the company responsible for opening the blockchain session of the WAIC conference, we have no doubt that our keynote will be closely listened to by other attendees and VIPs invited to the event.

Recommended AI News:Gryphon Investors Announces Majority Investment In 3Cloud

On20 April 2020,ChinasNational Development and Reform Commission (NDRC), the cabinet-level department that draws up policies and strategies for the direction of the Chinese economy,has expanded its definition of new infrastructure to include blockchain technology.

Investment in new infrastructure is expected to comprise 7%-12% of all infrastructure spending,with China International Capital Corporation (CICC) seeing new infrastructure investment of between 1-1.8 trillion yuan. As blockchain technology is becoming one of the major technical forces to boost the post-COVID economy, WAIC intends to open more discussions around its development.

With the theme of Intelligent Connectivity Indivisible Community, this Conference will be a high level platform attracting the most influential scientists and entrepreneurs around the world as well as government leaders to converse and talk about the technological frontiers, industry trends and provoking issues in forms of speeches and high-level forums.

VeChain will capitalize on this massive opportunity to pitch and share our experience and solutions to all stakeholders attending the conference. We are confident that our reputation and experience in solving pain points in the business world will convince even more partners to come onboard and expand our networking opportunities.

Recommended AI News:Scality Affirms Commitment To Open Source As Founding Member Of New Linux Foundation

See the rest here:

VeChain Is Attending the World Artificial Intelligence Conference 2020 Hosted - AiThority

How Machine Learning Will Impact the Future of Software Development and Testing – ReadWrite

Machine learning (ML) and artificial intelligence (AI) are frequently imagined to be the gateways to a futuristic world in which robots interact with us like people and computers can become smarter than humans in every way. But of course, machine learning is already being employed in millions of applications around the worldand its already starting to shape how we live and work, often in ways that go unseen. And while these technologies have been likened to destructive bots or blamed for artificial panic-induction, they are helping in vast ways from software to biotech.

Some of the sexier applications of machine learning are in emerging technologies like self-driving cars; thanks to ML, automated driving software can not only self-improve through millions of simulations, it can also adapt on the fly if faced with new circumstances while driving. But ML is possibly even more important in fields like software testing, which are universally employed and used for millions of other technologies.

So how exactly does machine learning affect the world of software development and testing, and what does the future of these interactions look like?

A Briefer on Machine Learning and Artificial Intelligence

First, lets explain the difference between ML and AI, since these technologies are related, but often confused with each other. Machine learning refers to a system of algorithms that are designed to help a computer improve automatically through the course of experience. In other words, through machine learning, a function (like facial recognition, or driving, or speech-to-text) can get better and better through ongoing testing and refinement; to the outside observer, the system looks like its learning.

AI is considered an intelligence demonstrated by a machine, and it often uses ML as its foundation. Its possible to have a ML system without demonstrating AI, but its hard to have AI without ML.

The Importance of Software Testing

Now, lets take a look at software testinga crucial element of the software development process, and arguably, the most important. Software testing is designed to make sure the product is functioning as intended, and in most cases, its a process that plays out many times over the course of development, before the product is actually finished.

Through software testing, you can proactively identify bugs and other flaws before they become a real problem, and correct them. You can also evaluate a products capacity, using tests to evaluate its speed and performance under a variety of different situations. Ultimately, this results in a better, more reliable productand lower maintenance costs over the products lifetime.

Attempting to deliver a software product without complete testing would be akin to building a large structure devoid of a true foundation. In fact, it is estimated that the cost of post software delivery can 4-5x the overall cost of the project itself when proper testing has not been fully implemented. When it comes to software development, failing to test is failing to plan.

How Machine Learning Is Reshaping Software Testing

Here, we can combine the two. How is machine learning reshaping the world of software development and testing for the better?

The simple answer is that ML is already being used by software testers to automate and improve the testing process. Its typically used in combination with the agile methodology, which puts an emphasis on continuous delivery and incremental, iterative developmentrather than building an entire product all at once. Its one of the reasons, I have argued that the future of agile and scrum methodologies involve a great deal of machine learning and artificial intelligence.

Machine learning can improve software testing in many ways:

While cognitive computing holds the promise of further automating a mundane, but hugely important process, difficulties remain. We are nowhere near the level of process automation acuity required for full-blown automation. Even in todays best software testing environments, machine learning aids in batch processing bundled code-sets, allowing for testing and resolving issues with large data without the need to decouple, except in instances when errors occur. And, even when errors do occur, the structured ML will alert the user who can mark the issue for future machine or human amendments and continue its automated testing processes.

Already, ML-based software testing is improving consistency, reducing errors, saving time, and all the while, lowering costs. As it becomes more advanced, its going to reshape the field of software testing in new and even more innovative ways. But, the critical piece there is going to. While we are not yet there, we expect the next decade will continue to improve how software developers iterate toward a finished process in record time. Its only one reason the future of software development will not be nearly as custom as it once was.

Nate Nead is the CEO of SEO.co/; a full-service SEO company and DEV.co/; a custom web and software development business. For over a decade Nate had provided strategic guidance on technology and marketing solutions for some of the most well-known online brands. He and his team advise Fortune 500 and SMB clients on software, development and online marketing. Nate and his team are based in Seattle, Washington and West Palm Beach, Florida.

Excerpt from:

How Machine Learning Will Impact the Future of Software Development and Testing - ReadWrite

How Old Is Your Dog in Human Years? Scientists Develop Better Method than ‘Multiply by 7’ – UC San Diego Health

If theres one myth that has persisted through the years without much evidence, its this: multiply your dogs age by seven to calculate how old they are in human years. In other words, the old adage says, a four-year-old dog is similar in physiological age to a 28-year-old person.

But a new study by researchers at University of California San Diego School of Medicine throws that out the window. Instead, they created a formula that more accurately compares the ages of humans and dogs. The formula is based on the changing patterns of methyl groups in dog and human genomes how many of these chemical tags and where theyre located as they age. Since the two species dont age at the same rate over their lifespans, it turns out its not a perfectly linear comparison, as the 1:7 years rule-of-thumb would suggest.

To calculate your dogs age in human years based on epigenetics, find the dogs age along the bottom axis and trace your finger straight up until you reach the red curve. Then trace your finger straight over to the left to find the corresponding human age. Credit: Cell Press

The new methylation-based formula, published July 2 in Cell Systems, is the first that is transferrable across species. More than just a parlor trick, the researchers say it may provide a useful tool for veterinarians, and for evaluating anti-aging interventions.

There are a lot of anti-aging products out there these days with wildly varying degrees of scientific support, said senior author Trey Ideker, PhD, professor at UC San Diego School of Medicine and Moores Cancer Center. But how do you know if a product will truly extend your life without waiting 40 years or so? What if you could instead measure your age-associated methylation patterns before, during and after the intervention to see if its doing anything? Ideker led the study with first author Tina Wang, PhD, who was a graduate student in Idekers lab at the time.

The formula provides a new epigenetic clock, a method for determining the age of a cell, tissue or organism based on a readout of its epigenetics chemical modifications like methylation, which influence which genes are off or on without altering the inherited genetic sequence itself.

Epigenetic changes provide scientists with clues to a genomes age, Ideker said much like wrinkles on a persons face provide clues to their age.

Ideker and others have previously published epigenetic clocks for humans, but they are limited in that they may only be accurate for the specific individuals on whom the formulas were developed. They dont translate to other species, perhaps not even to other people.

Ideker said it was Wang who first brought the dog idea to him.

We always look at humans, but humans are kind of boring, he said. So she convinced me we should study dog aging in a comparative way.

To do that, Ideker and Wang collaborated with dog genetics experts Danika Bannasch, DVM, PhD, professor of population health and reproduction at UC Davis School of Veterinary Medicine, and Elaine Ostrander, PhD, chief of the Cancer Genetics and Comparative Genomics Branch at the National Human Genome Research Institute, part of the National Institutes of Health. Bannasch provided blood samples from 105 Labrador retrievers. As the first to sequence the dog genome, Ostrander provided valuable input on analyzing it.

First author Tina Wang, PhD, (right) with her husband, Brandon, and their dog, Belli, who inspired the study. Photo courtesy of Tina Wang.

Dogs are an interesting animal to study, Ideker said. Given how closely they live with us, perhaps more than any other animal, a dogs environmental and chemical exposures are very similar to humans, and they receive nearly the same levels of health care. Its also important that we better understand their aging process, he said, as veterinarians frequently use the old 1:7 years ratio to determine a dogs age and use that information to guide diagnostic and treatment decisions.

What emerged from the study is a graph that can be used to match up the age of your dog with the comparable human age. The comparison is not a 1:7 ratio over time. Especially when dogs are young, they age rapidly compared to humans. A one-year-old dog is similar to a 30-year-old human. A four-year-old dog is similar to a 52-year-old human. Then by seven years old, dog aging slows.

This makes sense when you think about it after all, a nine-month-old dog can have puppies, so we already knew that the 1:7 ratio wasnt an accurate measure of age, Ideker said.

According to Ideker, one limitation of the new epigenetic clock is that it was developed using a single breed of dog, and some dog breeds are known to live longer than others. More research will be needed, but since its accurate for humans and mice as well as Labrador retrievers, he predicts the clock will apply to all dog breeds.

Next, the researchers plan to test other dog breeds, determine if the results hold up using saliva samples, and test mouse models to see what happens to their epigenetic markers when you try to prolong their lives with a variety of interventions.

Meanwhile, Ideker, like many other dog owners, is looking at his own canine companion a little differently now.

I have a six-year-old dog she still runs with me, but Im now realizing that shes not as young as I thought she was, Ideker said.

Co-authors of the study also include: Jianzhu Ma, Samson Fong, Katherine Licon, Brian Tsui, Jason F. Kreisberg, UC San Diego; Andrew N. Hogan, National Human Genome Research Institute, National Institutes of Health; Peter D. Adams, Sanford Burnham Prebys Medical Discovery Institute; and Anne-Ruxandra Carvunis, University of Pittsburgh School of Medicine.

Funding for this research came, in part, from the National Institutes of Health (grants ES014811, GM108865, GM008666, AG031862 and DE022532; NHGRI intramural program), California Institute for Regenerative Medicine (CIRM), and Maxine Adler Endowed Chair Funds.

An earlier version of this paper was shared as a preprint on BioRxiv on November 19, 2019, prior to peer-review and publication in Cell Systems.

Disclosure: Trey Ideker is co-founder of Data4Cure, Inc., is on the Scientific Advisory Board, and has an equity interest. He is also on the Scientific Advisory Board of Ideaya BioSciences, Inc., has an equity interest, and receives sponsored research funding. The terms of these arrangements have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies.

Follow this link:
How Old Is Your Dog in Human Years? Scientists Develop Better Method than 'Multiply by 7' - UC San Diego Health